In the case–control study presented herein, we correlated genetic polymorphisms in three genes, DNMT1, DNMT3A and DNMT3B, with clinical parameters to consider the risk of female Caucasians developing breast cancer. This evidence concerns the gene DNMT3A and breast carcinoma.